SCHEMBL17675110

SCHEMBL17675110

Cc1ccnc(N2CCCC2)c1C(=O)N(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCN10A Q9Y5Y9 1/20 0.47
▸ HCRTR1 O43613 1/20 0.41
▸ HCRTR2 O43614 1/20 0.41
▸ CNR2 P34972 1/20 0.40
▸ TSHR P16473 5/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ GLA P06280 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ CHRM4 P08173 1/20 0.39
▸ CYP2D6 P10635 2/20 0.38
▸ CLK4 Q9HAZ1 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ CYP1A2 P05177 3/20 0.36
▸ CYP2C9 P11712 2/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ CYP3A4 P08684 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ MAP4K4 O95819 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26845639 0.72 KDM4E (0.49) SCN10ATSHRKDM4EALDH1A1GLA
SCHEMBL25389487 0.70 KMT2A (0.40) SCN10ATSHRALDH1A1CYP2D6CYP1A2
SCHEMBL21921085 0.69 KDM4E (0.46) SCN10ATSHRKDM4EALDH1A1GLA
SCHEMBL20517299 0.69 KDM4E (0.46) SCN10ATSHRKDM4EALDH1A1GLA
SCHEMBL20517193 0.68 KDM4E (0.49) SCN10ACNR2TSHRKDM4EALDH1A1
SCHEMBL17145075 0.68 KMT2A (0.48) CNR2TSHRKDM4EALDH1A1GLA
SCHEMBL18135111 0.68 HRH4 (0.48) CNR2KDM4EALDH1A1GAACYP1A2
SCHEMBL17145030 0.67 KMT2A (0.47) CNR2TSHRKDM4EALDH1A1GLA
SCHEMBL38653920 0.66 KDM4E (0.42) SCN10ATSHRKDM4EALDH1A1GLA
SCHEMBL2224245 0.66 MAPT (0.44) SCN10AKDM4ELMNAMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3203840-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2017-08-16 — — EP disclosed
WO-2016057572-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MILLER MARK THOMAS (US) 2016-04-14 — — WO disclosed
Send feedback